$0.8108
-0.0172-2.08%
Last update: Nov 9, 7:33 AM

The average analyst price target for Biofrontera is $2.88, 255.2% above the current price. Targets range from $2.75 to $3. The latest change came on May 19, 2026, when Benchmark downgraded Biofrontera from Buy to Speculative Buy with a $3 price target.
Price Target Range — 4 Quarters
Analyst Consensus
Rating Trend — Last 9 Months